EUVIMEDEUVIMED entdecken
Crossref

Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors

Chun-Xia Zheng, Yu-Ting Liao, Hua-Xiang Wang, Chen Yang, Dashan Li, Li-Dong Shao iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Chun-Xia Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Southern Medicinal Resources, School of Chinese Materia Medica, Yunnan University of Chinese Medicine Kunming 650500. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cell Proliferation, HSP90 Heat-Shock Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Science and Technology Talent and Platform Program, Top Young Talent of Ten Thousand Talents Program of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

24 C3′‐focused hybrids of aryl/penta‐1,4‐dien‐3‐one/amine (APDA) were designed and synthesized. Of these hybrids, 2 n demonstrated improved antiproliferative effects on HER2‐positive breast cancer cells (SKBr3 and BT474) and triple‐negative breast cancer (TNBC) cells (MDA‐MB‐231 and MDA‐MB‐468) with IC 50 values ranging from 7.45 to 10.75 μM, but less toxicity to normal breast cells MCF‐10A than the first generation of hybrid 1 . Additionally, 2 n retained its ability to inhibit HSP90C‐terminus, leading to the degradation of HSP90 client proteins HER2, EGFR, pAKT, AKT, and CDK4, without inducing a heat‐shock response. Notably, 2 n also demonstrated improved thermostability compared to 1 and maintained in vitro metabolic stability in simulated intestinal fluid. These findings will provide a scientific basis for developing HSP90C‐terminal inhibitors in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCell ProliferationHSP90 Heat-Shock ProteinsHumansAminesCell Line, TumorDose-Response Relationship, DrugDrug Screening Assays, AntitumorMolecular StructureStructure-Activity RelationshipAlkenes

Stichwörter der Autor:innen

HER2-positive breast cancerHSP90C-terminusdesign and synthesistriple-negative breast cancer

Substanzen

AminesAntineoplastic AgentsHSP90 Heat-Shock ProteinsAlkenes

Autor:innen und Institutionen

  • Yunnan Key Laboratory of Southern Medicinal Resources, School of Chinese Materia Medica, Yunnan University of Chinese Medicine Kunming 650500.

ORCID-Profile: Li-Dong Shao

Förderung

  • National Natural Science Foundation of China
  • Yunnan Science and Technology Talent and Platform Program
  • Top Young Talent of Ten Thousand Talents Program of Yunnan Province
  • Bioactive Ethnopharmacol Molecules Chemical Conversion and Application Innovation Team of Department of Education of Yunnan Province
  • Start-up Fund of Yunnan University of Chinese Medicine

Zitieren

APA

Zheng, C. X., Liao, Y. T., Wang, H. X., Yang, C., Li, D., & Shao, L. D. (2024). Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400870

Vancouver

Zheng CX, Liao YT, Wang HX, Yang C, Li D, Shao LD. Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400870

BibTeX
@article{Zheng2024,
  author = {Zheng, Chun-Xia and Liao, Yu-Ting and Wang, Hua-Xiang and Yang, Chen and Li, Dashan and Shao, Li-Dong},
  title = {Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400870}
}
Kostenlos starten →